MRD-EDGE is out today in @NatureMedicine! Thrilled to see this in print when the future for #ctdna in plasma whole genome sequencing is brighter than ever.
How do you scale up liquid biopsy for use in routine cancer monitoring? Combine plasma-only ultrasensitive detection with cheap sequencing and a simple lab workflow. A big thanks to @AlexandrePCheng for pushing this work over the finish line! Stay tuned and more to come
What happens when sequencing costs go ⏬ ?
Imagination and new opportunities go ⏫ @landau_lab
Let's look at what you can do when you perform deep WGS on cfDNA for cancer detection. Our recent work with the @UltimaGenomics platform 🧵👇
Lets goooo!!
rdcu.be/ehkUb
Special nugget for my genomics friends in today's paper: Read everything but don't miss Extended Data Fig. 8, where @willbfx assembled a CCND1-ecDNA from @nanopore reads!
#NESTTrial 🪺 responses to date.🙌🏾
What’s particularly of note is the deepening of the responses with longer time to brew 🫖. The pattern🌊 and lack of recurrence speaks to curative potential of immunotherapy for both MSS and MSI-High tumors. #CRCSM@myESMO#ESMOGI24@OncoAlert
parts per million -> parts per billion -> parts per trillion? how low can we go with ctDNA detection in the era of dirt cheap whole genomes ?? .. momentous milestone by @adamjwidman@landau_lab & team👇👇👇
MRD-EDGE is out today in @NatureMedicine! Thrilled to see this in print when the future for #ctdna in plasma whole genome sequencing is brighter than ever.
MRD-EDGE is out today in @NatureMedicine! Thrilled to see this in print when the future for #ctdna in plasma whole genome sequencing is brighter than ever.
An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, says a team led by Dr. Dan Landau (@landau_lab) and researchers at @nygenome and @MSKCancerCenter.
bit.ly/45pXCJ3